Trial Profile
A trial to perform therapeutic drug monitoring and adjustment of posaconazole oral suspension in adults With acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Pharmacokinetics
- 22 Jun 2016 New trial record